Literature DB >> 9873019

Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts.

M Janulis1, S Silberman, A Ambegaokar, J S Gutkind, R M Schultz.   

Abstract

Ras activates a multitude of downstream activities with roles in cellular proliferation, invasion and metastasis, differentiation, and programmed cell death. In this work we have evaluated the requirement of extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase kinase (JNKK), and c-Jun/AP-1 activities in transformation and extracellular matrix invasion of ras oncogene expressing NIH 3T3 fibroblasts by expressing stable mutant genes that constitutively inhibit these activities. Whereas the inhibition of ERK activity reverts the transformed and invasive phenotype, the inhibition of the JNK pathway and AP-1 trans-activating activities by JNKK[K129R] and c-Jun(TAM67) had no effect on the ability of the ras oncogene-expressing cells to grow in soft agar or invade Matrigel basement membrane. Thus an elevated JNK activity and/or c-Jun/AP-1 trans-activating activity are not absolute requirements for ras transformation or invasion through basement membrane, and the dependence on AP-1 activity for transformation is cell-specific. However, inhibition of JNK kinase (JNKK) in ras-transformed cells with normally elevated JNK activity switches the protease-dependent invasive phenotype from a urokinase plasminogen activator (uPA)-dependent to a cathepsin L (CL)-dependent invasive phenotype. Conversely, treatment of ras-transformed cells of low constitutive JNK activity with the JNK stimulator, anisomycin, converts the protease mRNA levels from those characteristic of a CL-dependent to a uPA-dependent phenotype. These protease phenotypes can be duplicated in untransformed NIH 3T3 cells that express platelet-derived growth factor receptors and m1 muscarinic receptors that selectively stimulate the ERK or JNK pathways, respectively. It is concluded that high ERK activity is required for both protease phenotypes, whereas the JNK pathway and c-Jun/AP-1 activity are not required for transformation but regulate a switch between uPA and CL protease phenotypes in both transformed and untransformed cells. In ras-transformed NIH 3T3 fibroblasts, the uPA- and CL-dependent protease phenotypes are redundant in their ability to invade through basement membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9873019     DOI: 10.1074/jbc.274.2.801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Differential gene expression in stromal cells of human giant cell tumor of bone.

Authors:  M Wuelling; G Delling; E Kaiser
Journal:  Virchows Arch       Date:  2004-09-23       Impact factor: 4.064

2.  Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.

Authors:  C L Pethiyagoda; D R Welch; T P Fleming
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.

Authors:  Desmond J Tobin; Kerstin Foitzik; Thomas Reinheckel; Lars Mecklenburg; Vladimir A Botchkarev; Christoph Peters; Ralf Paus
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.

Authors:  N S Duesbery; J Resau; C P Webb; S Koochekpour; H M Koo; S H Leppla; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

5.  Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation.

Authors:  M Chiariello; M J Marinissen; J S Gutkind
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G Dipierro; Rana Abdel-Fattah; Samson Amos; Gerard T Redpath; Joan E Carpenter; Russell O Pieper; Isa M Hussaini
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

7.  Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages.

Authors:  Yinan Hua; Machender R Kandadi; Meijun Zhu; Jun Ren; Nair Sreejayan
Journal:  J Cardiovasc Pharmacol       Date:  2010-01       Impact factor: 3.105

8.  Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.

Authors:  Matthew H Herynk; Rachael Tsan; Robert Radinsky; Gary E Gallick
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Mutational activation of the MAP3K8 protooncogene in lung cancer.

Authors:  Adam Michael Clark; Steven H Reynolds; Marshall Anderson; Jonathan S Wiest
Journal:  Genes Chromosomes Cancer       Date:  2004-10       Impact factor: 5.006

10.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.